← All stocks

Aardvark Therapeutics, Inc.

AARD Net buying

CIK 0001774857 #4182 in the set updated 17 Sep 2026

Bought (12 mo)

$144.60K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$394.96K

$394.96K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 2 sales

Net

−$250.36K

+$144.60K against sales at will

By person

7 insiders · 6 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sun Nelson

See Remarks

$43.20K (1)

$394.96K (2) scheduled

−$351.76K

35,475

0.1621%

$183.77K

−58.9%

Lee Tien-Li

Chief Executive Officer

$101.40K (1)

—

+$101.40K

1,551,613

7.09%

$8.04M

+7.9%

Vickers Venture Fund VI Pte Ltd entity

10% owner

—

2,050,902

9.37%

$10.62M

—

Cormorant Asset Management, LP entity

Former 10% Owner

—

987,689

4.51%

$5.12M

—

Decheng Capital Global Life Sciences Fund IV, L.P. entity

10% owner

—

958,412

4.38%

$4.96M

—

Chi Jeffrey

Director

—

133,364

0.6094%

$690.87K

—

Jones Bryan

Chief Operating Officer

—

1,250

0.0057%

$6.48K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Sun Nelson

11 Sep 2026

See Remarks

Sold on a plan

62,000

$5.18

$321.18K

Sun Nelson

10 Sep 2026

See Remarks

Sold on a plan

14,754

$5.00

$73.78K

Show all 6 transactions →

What was left out

Form 4 filings counted 12

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 2,479

History held since 19 Feb 2025